International Seroepidemiology of Adenovirus Serotypes 5, 26, 35, and 48 in Pediatric and Adult Populations

Recombinant adenovirus serotype 5 (rAd5) vaccine vectors for HIV-1 and other pathogens have been shown to be limited by high titers of Ad5 neutralizing antibodies (NAbs) in the developing world. Alternative serotype rAd vectors have therefore been constructed. Here we report Ad5, Ad26, Ad35, and Ad4...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Barouch, Dan H., Kik, Sandra V., Weverling, Gerrit J., Dilan, Rebecca, King, Sharon L., Maxfield, Lori F., Clark, Sarah, Ng’ang’a, David, Brandariz, Kara L., Abbink, Peter, Sinangil, Faruk, Bruyn, Guy de, Gray, Glenda E., Roux, Surita, Bekker, Linda-Gail, Dilraj, Athmanundh, Kibuuka, Hannah, L. Robb, Merlin, Michael, Nelson L., Anzala, Omu, Amornkul, Pauli N., Gilmour, Jill, Hural, John, Buchbinder, Susan P., Seaman, Michael S., Dolin, Raphael, Baden, Lindsey R., Carville, Angela, Mansfield, Keith G., Pau, Maria G., Goudsmit, Jaap
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138857/
https://ncbi.nlm.nih.gov/pubmed/21619905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.05.025
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg